Global Mesalamine Market Research Report 2022 (Status and Outlook)

Report Overview:

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The Global Mesalamine Market Size was estimated at USD 156.40 million in 2021 and is projected to reach USD 194.90 million by 2028, exhibiting a CAGR of 3.19% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Mesalamine market covering all its essential aspects. This ranges from a macro-overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Mesalamine Market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Mesalamine market in any manner.

Global Mesalamine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Syntese A/S

Divis Laboratories

Cambrex Corporation

Ipca Laboratories

Hangzhou Brother

PharmaZell

Lianyungang Fengheng Biopharm

Lasa Loboratory

Erregierre SpA

Corden Pharma Bergamo

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Market Segmentation (by Type)

Purity ≥ 97%

Purity ≥ 98%

Purity ≥ 99%

Market Segmentation (by Application)

Mesalazine Tablets

Mesalazine Capsules

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study

• Neutral perspective on the market performance

• Recent industry trends and developments

• Competitive landscape & strategies of key players

• Potential & niche segments and regions exhibiting promising growth covered

• Historical, current, and projected market size, in terms of value

• In-depth analysis of the Biobased Transformer Oil Market

• Overview of the regional outlook of the Biobased Transformer Oil Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

• This enables you to anticipate market changes to remain ahead of your competitors

• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

• Provision of market value (USD Billion) data for each segment and sub-segment

• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

• Provides insight into the market through Value Chain

• Market dynamics scenario, along with growth opportunities of the market in the years to come

• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

TABLE OF CONTENTS

1 Research Methodology and Statistical Scope

1.1 Market Definition and Statistical Scope of Mesalamine

1.2 Key Market Segments

1.2.1 Mesalamine Segment by Type

1.2.2 Mesalamine Segment by Application

1.3 Methodology & Sources of Information

1.3.1 Research Methodology

1.3.2 Research Process

1.3.3 Market Breakdown and Data Triangulation

1.3.4 Base Year

1.3.5 Report Assumptions & Caveats

2 Mesalamine Market Overview

2.1 Global Market Overview

2.1.1 Global Mesalamine Market Size (M USD) Estimates and Forecasts (2017-2028)

2.1.2 Global Mesalamine Sales Estimates and Forecasts (2017-2028)

2.2 Market Segment Executive Summary

2.3 Global Market Size by Region

3 Mesalamine Market Competitive Landscape

3.1 Global Mesalamine Sales by Manufacturers (2017-2022)

3.2 Global Mesalamine Revenue Market Share by Manufacturers (2017-2022)

3.3 Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4 Global Mesalamine Average Price by Manufacturers (2017-2022)

3.5 Manufacturers Mesalamine Sales Sites, Area Served, Product Type

3.6 Mesalamine Market Competitive Situation and Trends

3.6.1 Mesalamine Market Concentration Rate

3.6.2 Global 5 and 10 Largest Mesalamine Players Market Share by Revenue

3.6.3 Mergers & Acquisitions, Expansion

4 Mesalamine Industry Chain Analysis

4.1 Mesalamine Industry Chain Analysis

4.2 Market Overview and Market Concentration Analysis of Key Raw Materials

4.3 Midstream Market Analysis

4.4 Downstream Customer Analysis

5 The Development and Dynamics of Mesalamine Market

5.1 Key Development Trends

5.2 Driving Factors

5.3 Market Challenges

5.4 Market Restraints

5.5 Industry News

5.5.1 New Product Developments

5.5.2 Mergers & Acquisitions

5.5.3 Expansions

5.5.4 Collaboration/Supply Contracts

5.6 Industry Policies

6 Mesalamine Market Segmentation by Type

6.1 Evaluation Matrix of Segment Market Development Potential (Type)

6.2 Global Mesalamine Sales Market Share by Type (2017-2022)

6.3 Global Mesalamine Market Size Market Share by Type (2017-2022)

6.4 Global Mesalamine Price by Type (2017-2022)

7 Mesalamine Market Segmentation by Application

7.1 Evaluation Matrix of Segment Market Development Potential (Application)

7.2 Global Mesalamine Market Sales by Application (2017-2022)

7.3 Global Mesalamine Market Size (M USD) by Application (2017-2022)

7.4 Global Mesalamine Sales Growth Rate by Application (2017-2022)

8 Mesalamine Market Segmentation by Region

8.1 Global Mesalamine Sales by Region

8.1.1 Global Mesalamine Sales by Region

8.1.2 Global Mesalamine Sales Market Share by Region

8.2 North America

8.2.1 North America Mesalamine Sales by Country

8.2.2 U.S.

8.2.3 Canada

8.2.4 Mexico

8.3 Europe

8.3.1 Europe Mesalamine Sales by Country

8.3.2 Germany

8.3.3 France

8.3.4 U.K.

8.3.5 Italy

8.3.6 Russia

8.4 Asia Pacific

8.4.1 Asia Pacific Mesalamine Sales by Region

8.4.2 China

8.4.3 Japan

8.4.4 South Korea

8.4.5 India

8.4.6 Southeast Asia

8.5 South America

8.5.1 South America Mesalamine Sales by Country

8.5.2 Brazil

8.5.3 Argentina

8.5.4 Columbia

8.6 Middle East and Africa

8.6.1 Middle East and Africa Mesalamine Sales by Region

8.6.2 Saudi Arabia

8.6.3 UAE

8.6.4 Egypt

8.6.5 Nigeria

8.6.6 South Africa

9 Key Companies Profiled

9.1 Syntese A/S

9.1.1 Syntese A/S Mesalamine Basic Information

9.1.2 Syntese A/S Mesalamine Product Overview

9.1.3 Syntese A/S Mesalamine Product Market Performance

9.1.4 Syntese A/S Business Overview

9.1.5 Syntese A/S Mesalamine SWOT Analysis

9.1.6 Syntese A/S Recent Developments

9.2 Divis Laboratories

9.2.1 Divis Laboratories Mesalamine Basic Information

9.2.2 Divis Laboratories Mesalamine Product Overview

9.2.3 Divis Laboratories Mesalamine Product Market Performance

9.2.4 Divis Laboratories Business Overview

9.2.5 Divis Laboratories Mesalamine SWOT Analysis

9.2.6 Divis Laboratories Recent Developments

9.3 Cambrex Corporation

9.3.1 Cambrex Corporation Mesalamine Basic Information

9.3.2 Cambrex Corporation Mesalamine Product Overview

9.3.3 Cambrex Corporation Mesalamine Product Market Performance

9.3.4 Cambrex Corporation Business Overview

9.3.5 Cambrex Corporation Mesalamine SWOT Analysis

9.3.6 Cambrex Corporation Recent Developments

9.4 Ipca Laboratories

9.4.1 Ipca Laboratories Mesalamine Basic Information

9.4.2 Ipca Laboratories Mesalamine Product Overview

9.4.3 Ipca Laboratories Mesalamine Product Market Performance

9.4.4 Ipca Laboratories Business Overview

9.4.5 Ipca Laboratories Mesalamine SWOT Analysis

9.4.6 Ipca Laboratories Recent Developments

9.5 Hangzhou Brother

9.5.1 Hangzhou Brother Mesalamine Basic Information

9.5.2 Hangzhou Brother Mesalamine Product Overview

9.5.3 Hangzhou Brother Mesalamine Product Market Performance

9.5.4 Hangzhou Brother Business Overview

9.5.5 Hangzhou Brother Mesalamine SWOT Analysis

9.5.6 Hangzhou Brother Recent Developments

9.6 PharmaZell

9.6.1 PharmaZell Mesalamine Basic Information

9.6.2 PharmaZell Mesalamine Product Overview

9.6.3 PharmaZell Mesalamine Product Market Performance

9.6.4 PharmaZell Business Overview

9.6.5 PharmaZell Recent Developments

9.7 Lianyungang Fengheng Biopharm

9.7.1 Lianyungang Fengheng Biopharm Mesalamine Basic Information

9.7.2 Lianyungang Fengheng Biopharm Mesalamine Product Overview

9.7.3 Lianyungang Fengheng Biopharm Mesalamine Product Market Performance

9.7.4 Lianyungang Fengheng Biopharm Business Overview

9.7.5 Lianyungang Fengheng Biopharm Recent Developments

9.8 Lasa Loboratory

9.8.1 Lasa Loboratory Mesalamine Basic Information

9.8.2 Lasa Loboratory Mesalamine Product Overview

9.8.3 Lasa Loboratory Mesalamine Product Market Performance

9.8.4 Lasa Loboratory Business Overview

9.8.5 Lasa Loboratory Recent Developments

9.9 Erregierre SpA

9.9.1 Erregierre SpA Mesalamine Basic Information

9.9.2 Erregierre SpA Mesalamine Product Overview

9.9.3 Erregierre SpA Mesalamine Product Market Performance

9.9.4 Erregierre SpA Business Overview

9.9.5 Erregierre SpA Recent Developments

9.10 Corden Pharma Bergamo

9.10.1 Corden Pharma Bergamo Mesalamine Basic Information

9.10.2 Corden Pharma Bergamo Mesalamine Product Overview

9.10.3 Corden Pharma Bergamo Mesalamine Product Market Performance

9.10.4 Corden Pharma Bergamo Business Overview

9.10.5 Corden Pharma Bergamo Recent Developments

9.11 CTX Lifescience

9.11.1 CTX Lifescience Mesalamine Basic Information

9.11.2 CTX Lifescience Mesalamine Product Overview

9.11.3 CTX Lifescience Mesalamine Product Market Performance

9.11.4 CTX Lifescience Business Overview

9.11.5 CTX Lifescience Recent Developments

9.12 Ishita Active Pharma Ingredients

9.12.1 Ishita Active Pharma Ingredients Mesalamine Basic Information

9.12.2 Ishita Active Pharma Ingredients Mesalamine Product Overview

9.12.3 Ishita Active Pharma Ingredients Mesalamine Product Market Performance

9.12.4 Ishita Active Pharma Ingredients Business Overview

9.12.5 Ishita Active Pharma Ingredients Recent Developments

9.13 YC Biotech (Jiangsu)

9.13.1 YC Biotech (Jiangsu) Mesalamine Basic Information

9.13.2 YC Biotech (Jiangsu) Mesalamine Product Overview

9.13.3 YC Biotech (Jiangsu) Mesalamine Product Market Performance

9.13.4 YC Biotech (Jiangsu) Business Overview

9.13.5 YC Biotech (Jiangsu) Recent Developments

9.14 Xinxiang Tianfeng Fine Chemical

9.14.1 Xinxiang Tianfeng Fine Chemical Mesalamine Basic Information

9.14.2 Xinxiang Tianfeng Fine Chemical Mesalamine Product Overview

9.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Product Market Performance

9.14.4 Xinxiang Tianfeng Fine Chemical Business Overview

9.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments

10 Mesalamine Market Forecast by Region

10.1 Global Mesalamine Market Size Forecast

10.2 Global Mesalamine Market Forecast by Region

10.2.1 North America Market Size Forecast by Country

10.2.2 Europe Mesalamine Market Size Forecast by Country

10.2.3 Asia Pacific Mesalamine Market Size Forecast by Region

10.2.4 South America Mesalamine Market Size Forecast by Country

10.2.5 Middle East and Africa Forecasted Consumption of Mesalamine by Country

11 Forecast Market by Type and by Application (2022-2028)

11.1 Global Mesalamine Market Forecast by Type (2022-2028)

11.1.1 Global Forecasted Sales of Mesalamine by Type (2022-2028)

11.1.2 Global Mesalamine Market Size Forecast by Type (2022-2028)

11.1.3 Global Forecasted Price of Mesalamine by Type (2022-2028)

11.2 Global Mesalamine Market Forecast by Application (2022-2028)

11.2.1 Global Mesalamine Sales (K Units) Forecast by Application

11.2.2 Global Mesalamine Market Size (M USD) Forecast by Application (2022-2028)

12 Conclusion and Key Findings

LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Mesalamine Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Mesalamine Sales (K Units) by Manufacturers (2017-2022)

Table 6. Global Mesalamine Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Mesalamine Revenue (M USD) by Manufacturers (2017-2022)

Table 8. Global Mesalamine Revenue Share by Manufacturers (2017-2022)

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2021)

Table 10. Global Market Mesalamine Average Price (USD/Unit) of Key Manufacturers (2017-2022)

Table 11. Manufacturers Mesalamine Sales Sites and Area Served

Table 12. Manufacturers Mesalamine Product Type

Table 13. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion Plans

Table 15. Industry Chain Map of Mesalamine

Table 16. Raw Materials

Table 17. Midstream Market Analysis

Table 18. Downstream Customer Analysis

Table 19. Key Development Trends

Table 20. Driving Factors

Table 21. Mesalamine Market Challenges

Table 22. Market Restraints

Table 23. Global Mesalamine Sales by Type (K Units)

Table 24. Global Mesalamine Market Size by Type (M USD)

Table 25. Global Mesalamine Sales (K Units) by Type (2017-2022)

Table 26. Global Mesalamine Sales Market Share by Type (2017-2022)

Table 27. Global Mesalamine Market Size (M USD) by Type (2017-2022)

Table 28. Global Mesalamine Market Size Share by Type (2017-2022)

Table 29. Global Mesalamine Price (USD/Unit) by Type (2017-2022)

Table 30. Global Mesalamine Sales (K Units) by Application

Table 31. Global Mesalamine Market Size by Application

Table 32. Global Mesalamine Sales by Application (2017-2022) & (K Units)

Table 33. Global Mesalamine Sales Market Share by Application (2017-2022)

Table 34. Global Mesalamine Sales by Application (2017-2022) & (M USD)

Table 35. Global Mesalamine Market Share by Application (2017-2022)

Table 36. Global Mesalamine Sales Growth Rate by Application (2017-2022)

Table 37. Global Mesalamine Sales by Region (2017-2022) & (K Units)

Table 38. Global Mesalamine Sales Market Share by Region (2017-2022)

Table 39. North America Mesalamine Sales by Country (2017-2022) & (K Units)

Table 40. Europe Mesalamine Sales by Country (2017-2022) & (K Units)

Table 41. Asia Pacific Mesalamine Sales by Region (2017-2022) & (K Units)

Table 42. South America Mesalamine Sales by Country (2017-2022) & (K Units)

Table 43. Middle East and Africa Mesalamine Sales by Region (2017-2022) & (K Units)

Table 44. Syntese A/S Mesalamine Basic Information

Table 45. Syntese A/S Mesalamine Product Overview

Table 46. Syntese A/S Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 47. Syntese A/S Business Overview

Table 48. Syntese A/S Mesalamine SWOT Analysis

Table 49. Syntese A/S Recent Developments

Table 50. Divis Laboratories Mesalamine Basic Information

Table 51. Divis Laboratories Mesalamine Product Overview

Table 52. Divis Laboratories Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 53. Divis Laboratories Business Overview

Table 54. Divis Laboratories Mesalamine SWOT Analysis

Table 55. Divis Laboratories Recent Developments

Table 56. Cambrex Corporation Mesalamine Basic Information

Table 57. Cambrex Corporation Mesalamine Product Overview

Table 58. Cambrex Corporation Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 59. Cambrex Corporation Business Overview

Table 60. Cambrex Corporation Mesalamine SWOT Analysis

Table 61. Cambrex Corporation Recent Developments

Table 62. Ipca Laboratories Mesalamine Basic Information

Table 63. Ipca Laboratories Mesalamine Product Overview

Table 64. Ipca Laboratories Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 65. Ipca Laboratories Business Overview

Table 66. Ipca Laboratories Mesalamine SWOT Analysis

Table 67. Ipca Laboratories Recent Developments

Table 68. Hangzhou Brother Mesalamine Basic Information

Table 69. Hangzhou Brother Mesalamine Product Overview

Table 70. Hangzhou Brother Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 71. Hangzhou Brother Business Overview

Table 72. Hangzhou Brother Mesalamine SWOT Analysis

Table 73. Hangzhou Brother Recent Developments

Table 74. PharmaZell Mesalamine Basic Information

Table 75. PharmaZell Mesalamine Product Overview

Table 76. PharmaZell Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 77. PharmaZell Business Overview

Table 78. PharmaZell Recent Developments

Table 79. Lianyungang Fengheng Biopharm Mesalamine Basic Information

Table 80. Lianyungang Fengheng Biopharm Mesalamine Product Overview

Table 81. Lianyungang Fengheng Biopharm Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 82. Lianyungang Fengheng Biopharm Business Overview

Table 83. Lianyungang Fengheng Biopharm Recent Developments

Table 84. Lasa Loboratory Mesalamine Basic Information

Table 85. Lasa Loboratory Mesalamine Product Overview

Table 86. Lasa Loboratory Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 87. Lasa Loboratory Business Overview

Table 88. Lasa Loboratory Recent Developments

Table 89. Erregierre SpA Mesalamine Basic Information

Table 90. Erregierre SpA Mesalamine Product Overview

Table 91. Erregierre SpA Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 92. Erregierre SpA Business Overview

Table 93. Erregierre SpA Recent Developments

Table 94. Corden Pharma Bergamo Mesalamine Basic Information

Table 95. Corden Pharma Bergamo Mesalamine Product Overview

Table 96. Corden Pharma Bergamo Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 97. Corden Pharma Bergamo Business Overview

Table 98. Corden Pharma Bergamo Recent Developments

Table 99. CTX Lifescience Mesalamine Basic Information

Table 100. CTX Lifescience Mesalamine Product Overview

Table 101. CTX Lifescience Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 102. CTX Lifescience Business Overview

Table 103. CTX Lifescience Recent Developments

Table 104. Ishita Active Pharma Ingredients Mesalamine Basic Information

Table 105. Ishita Active Pharma Ingredients Mesalamine Product Overview

Table 106. Ishita Active Pharma Ingredients Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 107. Ishita Active Pharma Ingredients Business Overview

Table 108. Ishita Active Pharma Ingredients Recent Developments

Table 109. YC Biotech (Jiangsu) Mesalamine Basic Information

Table 110. YC Biotech (Jiangsu) Mesalamine Product Overview

Table 111. YC Biotech (Jiangsu) Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 112. YC Biotech (Jiangsu) Business Overview

Table 113. YC Biotech (Jiangsu) Recent Developments

Table 114. Xinxiang Tianfeng Fine Chemical Mesalamine Basic Information

Table 115. Xinxiang Tianfeng Fine Chemical Mesalamine Product Overview

Table 116. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 117. Xinxiang Tianfeng Fine Chemical Business Overview

Table 118. Xinxiang Tianfeng Fine Chemical Recent Developments

Table 119. Global Mesalamine Sales Forecast by Region (K Units)

Table 120. Global Mesalamine Market Size Forecast by Region (M USD)

Table 121. North America Mesalamine Sales Forecast by Country (2022-2028) & (K Units)

Table 122. North America Mesalamine Market Size Forecast by Country (2022-2028) & (M USD)

Table 123. Europe Mesalamine Sales Forecast by Country (2022-2028) & (K Units)

Table 124. Europe Mesalamine Market Size Forecast by Country (2022-2028) & (M USD)

Table 125. Asia Pacific Mesalamine Sales Forecast by Region (2022-2028) & (K Units)

Table 126. Asia Pacific Mesalamine Market Size Forecast by Region (2022-2028) & (M USD)

Table 127. South America Mesalamine Sales Forecast by Country (2022-2028) & (K Units)

Table 128. South America Mesalamine Market Size Forecast by Country (2022-2028) & (M USD)

Table 129. Middle East and Africa Mesalamine Consumption Forecast by Country (2022-2028) & (Units)

Table 130. Middle East and Africa Mesalamine Market Size Forecast by Country (2022-2028) & (M USD)

Table 131. Global Mesalamine Sales Forecast by Type (2022-2028) & (K Units)

Table 132. Global Mesalamine Market Size Forecast by Type (2022-2028) & (M USD)

Table 133. Global Mesalamine Price Forecast by Type (2022-2028) & (USD/Unit)

Table 134. Global Mesalamine Sales (K Units) Forecast by Application (2022-2028)

Table 135. Global Mesalamine Market Size Forecast by Application (2022-2028) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Mesalamine

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Mesalamine Market Size (M USD), 2017-2028

Figure 5. Global Mesalamine Market Size (M USD) (2017-2028)

Figure 6. Global Mesalamine Sales (K Units) & (2017-2028)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 9. Evaluation Matrix of Regional Market Development Potential

Figure 10. Mesalamine Market Size (M USD) by Country (M USD)

Figure 11. Mesalamine Sales Share by Manufacturers in 2020

Figure 12. Global Mesalamine Revenue Share by Manufacturers in 2020

Figure 13. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 14. Global Market Mesalamine Average Price (USD/Unit) of Key Manufacturers in 2020

Figure 15. The Global 5 and 10 Largest Players: Market Share by Mesalamine Revenue in 2021

Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 17. Global Mesalamine Market Share by Type

Figure 18. Sales Market Share of Mesalamine by Type (2017-2022)

Figure 19. Sales Market Share of Mesalamine by Type in 2021

Figure 20. Market Size Share of Mesalamine by Type (2017-2022)

Figure 21. Market Size Market Share of Mesalamine by Type in 2020

Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 23. Global Mesalamine Market Share by Application

Figure 24. Global Mesalamine Sales Market Share by Application (2017-2022)

Figure 25. Global Mesalamine Sales Market Share by Application in 2021

Figure 26. Global Mesalamine Market Share by Application (2017-2022)

Figure 27. Global Mesalamine Market Share by Application in 2020

Figure 28. Global Mesalamine Sales Growth Rate by Application (2017-2022)

Figure 29. Global Mesalamine Sales Market Share by Region (2017-2022)

Figure 30. North America Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 31. North America Mesalamine Sales Market Share by Country in 2020

Figure 32. U.S. Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 33. Canada Mesalamine Sales (K Units) and Growth Rate (2017-2022)

Figure 34. Mexico Mesalamine Sales (Units) and Growth Rate (2017-2022)

Figure 35. Europe Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 36. Europe Mesalamine Sales Market Share by Country in 2020

Figure 37. Germany Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 38. France Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 39. U.K. Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 40. Italy Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 41. Russia Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 42. Asia Pacific Mesalamine Sales and Growth Rate (K Units)

Figure 43. Asia Pacific Mesalamine Sales Market Share by Region in 2020

Figure 44. China Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 45. Japan Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 46. South Korea Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 47. India Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 48. Southeast Asia Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 49. South America Mesalamine Sales and Growth Rate (K Units)

Figure 50. South America Mesalamine Sales Market Share by Country in 2020

Figure 51. Brazil Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 52. Argentina Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 53. Columbia Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 54. Middle East and Africa Mesalamine Sales and Growth Rate (K Units)

Figure 55. Middle East and Africa Mesalamine Sales Market Share by Region in 2020

Figure 56. Saudi Arabia Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 57. UAE Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 58. Egypt Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 59. Nigeria Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 60. South Africa Mesalamine Sales and Growth Rate (2017-2022) & (K Units)

Figure 61. Global Mesalamine Sales Forecast by Volume (2017-2028) & (K Units)

Figure 62. Global Mesalamine Market Size Forecast by Value (2017-2028) & (M USD)

Figure 63. Global Mesalamine Sales Market Share Forecast by Type (2022-2028)

Figure 64. Global Mesalamine Market Share Forecast by Type (2022-2028)

Figure 65. Global Mesalamine Sales Forecast by Application (2022-2028)

Figure 66. Global Mesalamine Market Share Forecast by Application (2022-2028)